Lyme Disease Diagnostic Devices Market By Diagnostic Tests & By Technologies 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Lyme disease diagnostic devices market
Lyme Disease Diagnostic Devices Market Analysis: By Diagnostic Tests (Serological, Lymphocytic Transformation, PCR Analysis, Immunofluorescence Staining); By Technologies (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry) - Forecast (2015 -2020)
Report Code : HCR 0047
Published: 22 June, 2015   No. of pages: 180

  • Report Description
  • Table of Contents
  • Customization Options
Lyme disease caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular, is the most commonly reported vector-borne illness in the United States. Lyme disease incidence is increasing throughout the world.

Lyme disease diagnostic devices market has been segmented by diagnostic tests, diagnostic technologies and end users. Each of these segmentations has been further classified into sub segments to give an in-depth and comprehensive analysis of the Lyme disease diagnostic devices market.

Further the report provides geographic analysis of the Lyme disease and lists major companies involved in manufacturing of innovative diagnostic devices devices for the treatment of Lyme disease.
1. Lyme Disease diagnostic devices Market Overview
2. Executive Summary
3. Lyme Disease diagnostic devices - Market Landscape
   3.1 Market Share Analysis
   3.2 Comparative Analysis
      3.2.1 Product Benchmarking
      3.2.2 Patent Analysis
      3.2.3 Top 5 Financials Analysis
4. Lyme Disease diagnostic devices - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4 Attractiveness of the Industry
      4.4.1 Power of Suppliers
      4.4.2 Power of Customers
      4.4.3 Threat of New entrants
      4.4.4 Threat of Substitution
      4.4.5 Degree of Competition
5. Lyme Disease diagnostic devices – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Opportunities Analysis
   5.3. Product lifecycle
   5.4. Pricing Analysis
6. Lyme Disease diagnostic devices - market By Diagnostic Tests
   6.1 Serological tests
      6.1.1 ELISA (Enzyme-linked Immunosorbent Assay)
      6.1.2 ELFA (Enzyme-linked Fluorescent Immunoassay)
      6.1.3 Western Blot
   6.2 Lymphocytic transformation test
   6.3 Immunofluorescence staining 
   6.4 PCR Analysis 
   6.5 Urine antigen tests
   6.6 Dark field microscopy
7. Lyme Disease diagnostic devices - market By Diagnostic Technologies
   7.1 Molecular diagnostics
   7.2 Brain MRI
   7.3 Spinal tap
   7.4 Echocardiogram
   7.5 Electrocardiogram
   7.6 Monoclonal antibodies 
   7.7 Flow cytometry
   7.8 Gel micro droplets
8. Lyme Disease diagnostic devices - market By End Users
   8.1 Hospitals / Clinics
   8.2 Pharmaceutical Industries
   8.3 Pathology labs
   8.4 Research Institutes
9. Lyme Disease diagnostic devices - market By Geographic Analysis
   9.1 Americas
      9.1.1. USA
      9.1.2. Canada
   9.2 Europe
      9.2.1 United kingdom
      9.2.3 Slovenia 
      9.2.3 Austria
      9.2.4 Italy
      9.2.5 Portugal
   9.3 Africa
      9.3.1 Morocco
      9.3.2 Algeria
      9.3.3 Egypt
      9.3.4 Tunisia
   9.4 Asia-Pacific
      9.4.1 Japan
      9.4.2 China
      9.4.3 India
      9.4.4 Thailand 
      9.4.5 Russia
      9.4.6 Others
   9.5 ROW
10. Company Profiles
   10.1 Abbott Laboratories
   10.2 Canon U.S. Life Sciences
   10.3 T2 Biosystems
   10.4 Bio-Rad Laboratories
   10.5 Alere Inc (ALR)
   10.6 Roche Diagnostics International Ltd.
   10.7 Graphene Frontiers
   10.8 Covance Inc.
   10.9 Boulder Diagnostics
   10.10 Immunetics Inc.
   10.11 GlaxoSmithKline Pharmaceuticals Ltd.
   10.12 Affymetrix Inc.
   10.13 Siemens AG 
   10.14 Baxter International Inc.
   10.15 Fresenius Medical Care AG & Co.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports